Network Leads Clinical Trials that Address Antibacterial Resistance Threats
As antibiotic-resistant bacteria become more urgent threats worldwide, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will provide up to $102.5 million in renewed funding over seven years for the Antibacterial Resistance Leadership Group (ARLG). This global consortium of scientific experts leads a comprehensive clinical research network overseeing research on important scientific questions related to antibacterial resistance. The renewed funding from NIAID will provide Duke University, Durham, North Carolina, which will coordinate the ARLG, with support to continue as well as enhance the ARLG’s research activities. According to the Centers for Disease Control and Prevention, antibacterial resistance is already a serious concern—more than 35,000 people die in the United States alone each year from antibiotic-resistant infections.
The post NIH Renews Funding for the Antibacterial Resistance Leadership Group appeared first on Healthier Environment Living Program.